CHATSWORTH, Calif., Jan. 20, 2010 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, announced today that its Board of Directors has approved an amendment to the Company’s by-laws to adopt a majority vote standard for election of directors, beginning with the next election of directors at the Company’s Annual Meeting of Stockholders in May.
